[ad_1]
The European Medicines Agency (EMA) holds a press conference on the AstraZeneca vaccine.
After Norway, Denmark and several other countries suspended use of the vaccine for fear that it would cause a blood clot, the EMA’s Risk Analysis Committee (PRAC) has conducted a new evaluation of the vaccine.
The press conference was supposed to start at 4 in the afternoon, but was postponed until 5 in the afternoon.
EMA chief Emer Cooke says they have concluded that it is a safe and effective vaccine.
The Norwegian health authorities have announced a press conference on the vaccine at 6.30 pm.
– The cause has been found.
Attached warning
– We cannot rule out that there is a link between blood clots and this vaccine. Therefore, we have decided to attach a warning to this vaccine, says Cooke.
The reason for this is that those who receive the vaccine should be aware that side effects can occur.
They cannot rule out that the vaccine may in some cases cause blood clots, but they still believe that the advantages outweigh the disadvantages of using the vaccine.
The EMA says at the press conference that they have thoroughly studied the reports of the Norwegian health authorities, but that the results of the Norwegian authorities today were not part of the assessment.
The head of the EMA would take it
The risk analysis committee has included, among other things, experts on blood clots at work. So far, seven cases of blood clots in various blood vessels have been reported among those vaccinated, while another 18 cases of blood clots have been reported, the EMA writes in a press release. So far, around 20 million people in the EU and the UK have been vaccinated with AstraZeneca.
– If it had been for me, I would have been vaccinated with this tomorrow, says Cooke.
You think side effects occur
She also says that they will continue to monitor for side effects.
“Our scientific evaluation is that this is a safe and effective vaccine to protect against Covid,” says Cooke.
He says that he is aware that several EU countries have stopped vaccination with this vaccine and therefore have set this process as their top priority.
“When millions of people are vaccinated, there will be rare side effects,” says Cooke.
